Trial Profile

Phase 3 study of alprostadil continuous intravenous infusion in bridging cardiac transplant in severe heart failure patients.

Status: Suspended

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Alprostadil (Primary)
Indications Heart failure
Focus Adverse reactions; Therapeutic Use

Most Recent Events

27 Jan 2021 Biomarkers information updated
07 Jun 2011 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.
05 Feb 2010 Planned end date changed from 1 Oct 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com